Given the previous reports outlining overexpression of RSPO3 in various cancers, we sought to investigate whether RSPO3 overexpression is observed in patient cohorts of human prostate cancer using Oncomine Platform (http://www.oncomine.com, April 2018), a repository of gene expression datasets. Here, RSPO3 is linked to cancer.